CD8A and neoplasm: The Immunoscore uses IHC to evaluate the number of CD3+ and CD8+ T cells at the tumor center (CT) and the invasive margin (IM; for Immunoscore, this is defined as a region encompassing 360 μm on either side of the invasive boundary; in our work, we set this to ±100 μm from the boundary)42.